title: Mirtazapine use in two pregnant women: is it safe?
authors.forename: Murat
authors.initials: M
authors.lastname: Kesim
authors.forename: Fusun
authors.initials: F
authors.lastname: Yaris
authors.forename: Mine
authors.initials: M
authors.lastname: Kadioglu
authors.forename: Ersin
authors.initials: E
authors.lastname: Yaris
authors.forename: Nuri Ihsan
authors.initials: NI
authors.lastname: Kalyoncu
authors.forename: Cunay
authors.initials: C
authors.lastname: Ulku
mesh_terms: D000328:Adult; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000009:adverse effects; D001007:Anxiety / Q000188:drug therapy; D003863:Depression / Q000188:drug therapy; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008803:Mianserin / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives; D000078785:Mirtazapine; D011247:Pregnancy / Q000523:psychology*; D011248:Pregnancy Complications / Q000188:drug therapy*; D011256:Pregnancy Outcome; D014268:Trifluoperazine / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000929:Antidepressive Agents, Tricyclic; D014268:Trifluoperazine; D008803:Mianserin; D000078785:Mirtazapine